Brief: Alkem Laboratories US FDA Inspection At Co's API Manufacturing Facility Located At Mandva
01/12/2023 15:13
Dec 1 (Reuters) - Alkem Laboratories Ltd ALKE.NS :
* US FDA INSPECTION AT COMPANY'S API MANUFACTURING FACILITY
LOCATED AT MANDVA
* CO RECEIVED FORM 483 WITH THREE OBSERVATIONS
* NO DATA INTEGRITY OBSERVATION
* US FDA HAD CONDUCTED INSPECTION FROM 27 NOVEMBER TO 1
DECEMBER
Source text for Eikon: ID:nBSE5T2THF
Further company coverage: ALKE.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees